Inken Harder
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 12, 2026
Real-world effectiveness and safety of tralokinumab therapy in moderate-to-severe atopic dermatitis: insights from the TREATgermany registry.Jan Hartmann, Inken Harder, Dora Stölzl
|Nov 28, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.Luise Heinrich, Thomas Birkner, Susanne Abraham
|Oct 25, 2024
Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.Coco Dekkers, Hidde Smits, Dora Stölzl
|May 31, 2024
Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data.Matthias Hübenthal, Chengliang Dai, Sara J Brown
|May 07, 2024
Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.D Stölzl, N Sander, D Siegels
Pageof 1
Frequent Collaborators
5 joint publications
Stephan Weidinger
4 joint publications
Jochen Schmitt
3 joint publications
Luise Heinrich
3 joint publications
Thomas Werfel
2 joint publications
Dora Stölzl
2 joint publications
Barbara Kind
2 joint publications
Susanne Abraham
1 joint publications
N Sander
1 joint publications
D Siegels
1 joint publications
M Fonfara
